Piramal Pharma Rights Issue 2023 vs SEPC Rights Issue 2023

Comparision between Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023. Piramal Pharma Rights Issue 2023 is listed on BSE, NSE while SEPC Rights Issue 2023 is listed on BSE, NSE.

	Piramal Pharma Limited	SEPC Limited
Logo
Listing At	BSE, NSE	BSE, NSE
Terms of Payment	The full amount of Rs. 81 for rights equity shares has to be paid on application.	The entire amount of the Issue Price of Rs.10/- per Rights Equity Share shall be payable at the time of Application.
Entitlement	5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date	2 Rights Equity Share(s) for every 53 fully paid-up Equity Shares held on Record Date
Application Form	Application Form	Application Form
Letter of Offer	Letter of Offer	Letter of Offer
Registrar	Link Intime India Private Ltd	Cameo Corporate Services Limited
Lead Managers	ICICI Securities Limited

Rights Issue Size and Price

The issue size of Piramal Pharma Rights Issue 2023 rights issue is ₹1,050.00 Crores, whereas SEPC Rights Issue 2023 rights issue size is ₹49.90 Crores.

	Piramal Pharma Limited	SEPC Limited
Issue Size	12,96,29,630 shares	4,99,00,000 shares
Issue Size (Amount)	₹1,050.00 Crores	₹49.90 Crores
Issue Price	₹81 per share	₹10 per share
Face Value	₹10 per share	₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023 while record date of SEPC Rights Issue 2023 is Mar 29, 2023.

	Piramal Pharma Limited	SEPC Limited
Record Date	Aug 02, 2023	Mar 29, 2023
Credit of Rights Entitlements
Bid/Offer Opens On	Aug 08, 2023	Apr 10, 2023
Renunciation of Rights Entitlements	Aug 10, 2023	Apr 18, 2023
Bid/Offer Closes On	Aug 17, 2023	Apr 24, 2023
Deemed Date of Allotment	Aug 23, 2023	May 03, 2023
Credit Date	Aug 24, 2023	May 05, 2023
Listing Date	Aug 28, 2023	May 08, 2023

Financials details

Comparison of Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

Piramal Pharma Limited

SEPC Limited

Financial

Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	10,899.78	12,797.04	14,522.56
Revenue	6,479.01	6,834.90	7,306.66
Profit After Tax	835.03	375.96	-186.46
Net Worth	5,076.75	6,069.94	5,968.45
Reserves and Surplus	4,488.62	5,290.69	5,181.79
Total Borrowing	2,910.19	4,023.28	5,504.77

Amount in ₹ Crore

SEPC Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax
31-Mar-20	2,602.65	1,258.87	-77.26
31-Mar-21	2,416.29	606.13	-179.47
31-Mar-22	2,223.22	340.59	-263.70
Amount in ₹ Crore

Compare with others

Piramal Pharma Limited	SEPC Limited
GI Engineering Solutions Rights Issue 2023	Som Distilleries Rights Issue 2023
Godha Cabcon & Insulation Rights Issue 2023	Prerna Infrabuild Rights Issue 2023
Rushil Decor Rights Issue 2023	Piramal Pharma Rights Issue 2023
Som Distilleries Rights Issue 2023	PNB Housing Finance Rights Issue
Prerna Infrabuild Rights Issue 2023	Shree Rama Multi-Tech Rights Issue 2023
PNB Housing Finance Rights Issue	MKVentures Capital Rights Issue 2023
Shree Rama Multi-Tech Rights Issue 2023	A.F. Enterprises Rights Issue 2023
SEPC Rights Issue 2023	Gokul Agro Resources Rights Issue 2023
MKVentures Capital Rights Issue 2023	Share India Securities Rights Issue 2023
A.F. Enterprises Rights Issue 2023	Veer Global Infraconstruction Rights Issue 2023

Comments

Add a public comment...